377 related articles for article (PubMed ID: 24682092)
1. The pharmacological rationale for combining muscarinic receptor antagonists and β-adrenoceptor agonists in the treatment of airway and bladder disease.
Dale PR; Cernecka H; Schmidt M; Dowling MR; Charlton SJ; Pieper MP; Michel MC
Curr Opin Pharmacol; 2014 Jun; 16(100):31-42. PubMed ID: 24682092
[TBL] [Abstract][Full Text] [Related]
2. Signal transduction underlying the control of urinary bladder smooth muscle tone by muscarinic receptors and beta-adrenoceptors.
Frazier EP; Peters SL; Braverman AS; Ruggieri MR; Michel MC
Naunyn Schmiedebergs Arch Pharmacol; 2008 Jun; 377(4-6):449-62. PubMed ID: 18060543
[TBL] [Abstract][Full Text] [Related]
3. Re: The Pharmacological rationale for combining muscarinic receptor antagonists and β-adrenoceptor agonists in the treatment of airway and bladder disease.
Wein AJ
J Urol; 2015 Jan; 193(1):218-9. PubMed ID: 25523672
[No Abstract] [Full Text] [Related]
4. Combination therapy with β3 -adrenoceptor agonists and muscarinic acetylcholine receptor antagonists: Efficacy in rats with bladder overactivity.
Furuta A; Suzuki Y; Kimura S; Koike Y; Egawa S; Yoshimura N
Int J Urol; 2016 May; 23(5):425-30. PubMed ID: 26890938
[TBL] [Abstract][Full Text] [Related]
5. Muscarinic agonists and antagonists: effects on the urinary bladder.
Sellers DJ; Chess-Williams R
Handb Exp Pharmacol; 2012; (208):375-400. PubMed ID: 22222707
[TBL] [Abstract][Full Text] [Related]
6. Muscarinic receptor subtypes and signalling involved in the attenuation of isoprenaline-induced rat urinary bladder relaxation.
Witte LP; de Haas N; Mammen M; Stangeland EL; Steinfeld T; Aiyar J; Michel MC
Naunyn Schmiedebergs Arch Pharmacol; 2011 Dec; 384(6):555-63. PubMed ID: 21947231
[TBL] [Abstract][Full Text] [Related]
7. Long-term nitric oxide deficiency causes muscarinic supersensitivity and reduces beta(3)-adrenoceptor-mediated relaxation, causing rat detrusor overactivity.
Mónica FZ; Bricola AA; Báu FR; Freitas LL; Teixeira SA; Muscará MN; Abdalla FM; Porto CS; De Nucci G; Zanesco A; Antunes E
Br J Pharmacol; 2008 Apr; 153(8):1659-68. PubMed ID: 18297104
[TBL] [Abstract][Full Text] [Related]
8. Similarities and differences in the autonomic control of airway and urinary bladder smooth muscle.
Michel MC; Parra S
Naunyn Schmiedebergs Arch Pharmacol; 2008 Aug; 378(2):217-24. PubMed ID: 18548230
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic modulation of urinary bladder function: multiple targets at multiple levels.
Michel MC
Annu Rev Pharmacol Toxicol; 2015; 55():269-87. PubMed ID: 25251997
[TBL] [Abstract][Full Text] [Related]
10. Do β-adrenoceptor agonists induce homologous or heterologous desensitization in rat urinary bladder?
Michel MC
Naunyn Schmiedebergs Arch Pharmacol; 2014 Mar; 387(3):215-24. PubMed ID: 24213882
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory mechanism of BRL37344 on muscarinic receptor-mediated contractions of the rat urinary bladder smooth muscle.
Kubota Y; Nakahara T; Yunoki M; Mitani A; Maruko T; Sakamoto K; Ishii K
Naunyn Schmiedebergs Arch Pharmacol; 2002 Sep; 366(3):198-203. PubMed ID: 12172701
[TBL] [Abstract][Full Text] [Related]
12. Muscarinic receptors in the bladder: from basic research to therapeutics.
Hegde SS
Br J Pharmacol; 2006 Feb; 147 Suppl 2(Suppl 2):S80-7. PubMed ID: 16465186
[TBL] [Abstract][Full Text] [Related]
13. Effects of (a Combination of) the Beta
Maarsingh H; Oldenburger A; Han B; Zuidhof AB; Elzinga CRS; Timens W; Meurs H; Sopi RB; Schmidt M
Cells; 2021 May; 10(5):. PubMed ID: 34069899
[TBL] [Abstract][Full Text] [Related]
14. Muscarinic receptor subtypes modulating smooth muscle contractility in the urinary bladder.
Hegde SS; Eglen RM
Life Sci; 1999; 64(6-7):419-28. PubMed ID: 10069505
[TBL] [Abstract][Full Text] [Related]
15. The scientific rationale for combining long-acting beta2-agonists and muscarinic antagonists in COPD.
Cazzola M; Molimard M
Pulm Pharmacol Ther; 2010 Aug; 23(4):257-67. PubMed ID: 20381630
[TBL] [Abstract][Full Text] [Related]
16. Pharmacologic characterization of GSK-961081 (TD-5959), a first-in-class inhaled bifunctional bronchodilator possessing muscarinic receptor antagonist and β2-adrenoceptor agonist properties.
Hegde SS; Hughes AD; Chen Y; Steinfeld T; Jasper JR; Lee TW; McNamara A; Martin WJ; Pulido-Rios MT; Mammen M
J Pharmacol Exp Ther; 2014 Oct; 351(1):190-9. PubMed ID: 25100753
[TBL] [Abstract][Full Text] [Related]
17. Research and development of bronchodilators for asthma and COPD with a focus on G protein/KCa channel linkage and β2-adrenergic intrinsic efficacy.
Kume H; Fukunaga K; Oguma T
Pharmacol Ther; 2015 Dec; 156():75-89. PubMed ID: 26432616
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological Characterization of a Novel Beta 3 Adrenergic Agonist, Vibegron: Evaluation of Antimuscarinic Receptor Selectivity for Combination Therapy for Overactive Bladder.
Di Salvo J; Nagabukuro H; Wickham LA; Abbadie C; DeMartino JA; Fitzmaurice A; Gichuru L; Kulick A; Donnelly MJ; Jochnowitz N; Hurley AL; Pereira A; Sanfiz A; Veronin G; Villa K; Woods J; Zamlynny B; Zycband E; Salituro GM; Frenkl T; Weber AE; Edmondson SD; Struthers M
J Pharmacol Exp Ther; 2017 Feb; 360(2):346-355. PubMed ID: 27965369
[TBL] [Abstract][Full Text] [Related]
19. Involvement of Allosteric Effect and K
Kume H; Nishiyama O; Isoya T; Higashimoto Y; Tohda Y; Noda Y
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29987243
[TBL] [Abstract][Full Text] [Related]
20. Muscarinic receptor subtypes in neuronal and non-neuronal cholinergic function.
Eglen RM
Auton Autacoid Pharmacol; 2006 Jul; 26(3):219-33. PubMed ID: 16879488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
